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OBJECTIVES We tested the hypothesis that left ventricular (LV) pacing is superior to right ventricular (RV)
apical pacing in patients undergoing atrioventricular (AV) junction ablation and pacing for
permanent atrial fibrillation.
BACKGROUND The potential benefit of LV over RV pacing needs to be evaluated without the confounding
effect of other variables that can influence cardiac performance.
METHODS An acute intrapatient comparison of the QRS width and echocardiographic parameters
between RV versus LV pacing was performed within 24 h after ablation in 44 patients. Both
modes of pacing were also compared with pre-implantation values.
RESULTS Compared with RV pacing, LV pacing caused a 5.7% increase in the ejection fraction (EF)
and a 16.7% decrease in the mitral regurgitation (MR) score; the QRS width was 4.8% shorter
with LV pacing. Similar results were observed in patients with or without systolic dysfunction
and/or native left bundle branch block, except for a greater improvement in MR in the latter
group. Compared with pre-ablation measures, the EF increased by 11.2% and 17.6% with RV
and LV pacing, respectively; the MR score decreased by 0% and 16.7%; and the diastolic
filling time increased by 12.7% and 15.6%.
CONCLUSIONS Rhythm regularization achieved with AV junction ablation improved EF with both RV and
LV pacing; LV pacing provided an additional modest but favorable hemodynamic effect, as
reflected by a further increase of EF and reduction of MR. The effect seems to be equal in
patients with both depressed and preserved systolic functions and in those with and without
native left bundle branch block. (J Am Coll Cardiol 2004;43:234–8) © 2004 by the
American College of Cardiology Foundation
Pacing from the apex of the right ventricle (RV) is consid-
ered not optimal, as it provides a nonphysiologic asynchro-
nous contraction, which results in a decrease in cardiac
performance (1,2). In patients with permanent atrial fibril-
lation (AF) who received atrioventricular (AV) junction
ablation and pacing from the RV apex, the beneficial
See page 239
hemodynamic effect of regularization of heart rhythm is
thus assumed to be partly counteracted by the adverse
hemodynamic effect of a nonphysiologic pacing mode (3).
The Optimal Pacing Site (OPSITE) study (4) is a
prospective, randomized, single-blinded, cross-over com-
parison between RV and left ventricular (LV) pacing for
patients with permanent AF undergoing ablation and pac-
ing therapy. The study consists of acute and chronic-
evaluations. The protocol has been published previously (4).
In this report, we focus on the acute comparison of RV
and LV pacing in a model of AF and AV junction ablation,
which allows the net effect of LV over RV pacing to be
studied without the confounding effect of two other vari-
ables that can influence cardiac performance—namely, the
effect of atrial contribution (including the effect of the PR
interval) and the irregularity of the ventricular rhythm.
Single-site LV pacing was compared with single-site RV
pacing to eliminate the potential confounding effect of
simultaneous biventricular stimulation. Moreover, the acute
evaluation was performed shortly after ablation, allowing a
minimum time for cardiac adaptation, which is another
confounding factor.
We assumed that the acute hemodynamic effect of LV
pacing would be better than that of RV pacing. Secondary
objectives were the comparison between two predefined
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subgroups of patients with preserved or depressed systolic
function and the comparison of the two modes of pacing
with baseline measures to evaluate the effect of AV junction
ablation.
METHODS
The following patients were eligible for enrollment in the
OPSITE study: 1) patients with permanent AF in whom a
clinical decision was made to undertake complete AV
junction ablation and ventricular pacing because of a drug-
refractory, severely symptomatic, uncontrolled high ventric-
ular rate; and 2) patients with permanent AF, drug-
refractory heart failure, depressed LV function, and/or left
bundle branch block (LBBB) in whom a clinical decision
was made to undertake LV synchronization pacing.
Patient exclusion criteria were as follows: 1) New York
Heart Association functional class IV heart failure; 2) severe
concomitant noncardiac diseases; 3) need for surgical inter-
vention; 4) myocardial infarction within three months; 5)
sustained ventricular tachycardia or ventricular fibrillation;
and 6) previously implanted pacemaker.
Two different subgroups were predefined for analysis:
patients with an ejection fraction (EF) 40% and absence
of an LBBB pattern (group A) and patients with heart
failure (i.e., those with EF 40% and/or LBBB pattern)
(group B).
All patients underwent pacemaker implantation and AV
junction ablation; pacemaker implantation and ablation
could take place at different times (6 weeks apart), but
simultaneous procedures were recommended. The RV leads
were positioned in the RV apex. The LV leads were
positioned via the coronary sinus in a position considered
most appropriate by the implanting physician; in case of
failure of pacing through the coronary sinus, an epicardial
lead was inserted. A conventional dual-chamber pacemaker
was used; the atrial port of the pacemaker was connected to
the LV lead, and the ventricular port was connected to the
RV lead.
The acute noninvasive study, which was performed
within 24 h after AV junction ablation, consisted of echo-
cardiographic evaluation and measurements of the QRS
duration. The pacemaker was alternately programmed to
pace in the LV or RV only in randomized order, at a rate of
70 beats/min. The RV and LV pacing studies were per-
formed during the same session; the operator who per-
formed the test and analyzed the records was not informed
of the mode of pacing. The echocardiographic examination
was performed using standard views, according to the
guidelines of the American Society of Echocardiography
(5). Echocardiographic long-axis and apical two- and four-
chamber views were obtained to assess the LV end-diastolic
diameter, LV end-systolic diameter, EF (area–length
method), aortic flow integral (pulsed Doppler), isovolumic
relaxation time, mitral flow integral (pulsed Doppler),
mitral flow peak, mitral deceleration time, diastolic filling
time, and severity of mitral regurgitation (MR) (by means of
a semiquantitative three-score scale). The measures ob-
tained were the average of six consecutive beats.
Statistical analysis. The assumption for the sample size
calculation was that, based on a previous study (6), LV
pacing would be able to increase EF by 9%, compared with
RV pacing. The sample size able to provide 80% power to
show an intrapatient difference, with a probability of 95%,
was 40 patients. Paired and unpaired two-tailed t tests were
used for comparison of continuous variables. A value p 
0.05 was considered as significant.
RESULTS
The study group consisted of 44 patients who had under-
gone successful AV junction ablation and pacemaker im-
plantation between July 2001 and July 2002. The RV leads
were positioned in the RV apex in all patients. The LV leads
Abbreviations and Acronyms
AF  atrial fibrillation
AV  atrioventricular
EF  ejection fraction
LBBB  left bundle branch block
LV  left ventricle/ventricular
MR  mitral regurgitation
OPSITE  Optimal Pacing Site study
RV  right ventricle/ventricular
Table 1. Patient Characteristics at Enrollment (n  49)
Age (yrs) 72  8
Gender (males) 24 (54%)
Duration of atrial fibrillation (yrs) 5.9  4.2
No. of hospitalizations per patient 3.3  2.6
New York Heart Association functional class 2.4  0.5
Minnesota Living With Heart Failure Questionnaire (score) 49  17
6-min walking test (m) 292  103
Standard electrocardiogram
Mean heart rate (beats/min) 101  25
Left bundle branch block 22 (50%)
Other intraventricular conduction disturbances 10 (23%)
Holter monitoring
Minimum heart rate (beats/min) 65  32
Mean heart rate (beats/min) 91  18
Maximum heart rate (beats/min) 143  41
Associated structural heart disease
Coronary artery disease 15 (34%)
Others 29 (66%)
Concomitant medications
Digoxin 32 (72%)
Diuretics 35 (80%)
Nitrates 7 (16%)
Angiotensin-converting enzyme inhibitors 33 (75%)
Beta-blockers 22 (50%)
Calcium antagonists 10 (23%)
Apirin 4 (9%)
Warfarin 37 (84%)
Class I antiarrhythmic drugs 3 (7%)
Amiodarone 7 (16%)
Sotalol 1 (2%)
Data are presented as the mean value  SD or number (%) of patients.
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were positioned via the coronary sinus in the mid-
posterolateral site in 39 patients and in the anterior site in 3
patients. In two patients in whom the coronary sinus
approach had failed, the lead was implanted in an epicardial
mid-posterolateral position through a limited thoracotomy.
The clinical characteristics are shown in Table 1. Of these,
14 belonged to group A and 30 to group B (22 of group B
also had LBBB).
The results of the comparison between RV and LV
pacing are shown in Table 2. Compared with RV, LV
pacing resulted in a significant increase of EF, a decrease of
MR, and a small reduction of the QRS duration.
Similar results were observed in patients with normal
cardiac function (group A) and in those with depressed
systolic function (group B) for all variables except for MR,
which was more reduced in group A patients (Table 3).
Similar findings were also observed in patients with and
without native LBBB (Table 4). Among patients with
native LBBB, all but three also had an EF 40%.
A comparison with pre-implantation data is shown in
Table 2. Both RV and LV pacing improved EF and
prolonged the diastolic filling time; LV pacing also reduced
the MR score, whereas RV pacing did not. Both RV and
LV pacing decreased aortic and mitral stroke velocity, thus
suggesting a deleterious effect on contraction, but this effect
was less pronounced with LV pacing.
DISCUSSION
The main findings of this study are that rhythm regulariza-
tion achieved with AV junction ablation improves EF with
both RV and LV pacing; however, LV pacing gives an
additive modest but favorable hemodynamic effect, as
judged by a further increase of EF and reduction of MR
magnitude. This effect seems to be equal in patients with
and without depressed systolic function and in patients with
and without LBBB. As a consequence of the protocol used,
the effect of LV pacing could be evaluated without several
potentially confounding factors (i.e., the effect of atrial
contribution [including the effect of the PR interval],
irregularity of the ventricular rhythm, simultaneous biven-
Table 2. Results
Baseline RV Pacing LV Pacing
RV vs. Baseline LV vs. Baseline LV vs. RV
Difference
(%)
p
Value*
Difference
(%)
p
Value*
Difference
(%)
p
Value*
EF (%) 36.6  13.0 40.7  14.9 43.0  14.2 11.2 0.03 17.5 0.001 5.7 0.002
LVEDD (mm) 56.7  10.2 57.4  10.2 57.2  10.5 1.2 NS 0.9 NS 0.4 NS
LVESD (mm) 48.8  10.6 43.4  11.5 42.7  12.1 11.1 NS 12.5 NS 1.6 NS
IRT (ms) 84.7  21.2 79.9  30.2 78.8  28.1 5.7 NS 7.0 NS 1.3 NS
MR (score) 1.8  0.7 1.8  0.9 1.5  0.7 0 NS 16.7 0.002 16.7 0.001
FVI Ao (cm) 19.7  8.9 17.6  6.8 18.7  6.8 10.7 0.02 5.1 NS 6.2 NS
Emax (cm/s) 106.9  34.6 104.5  31.2 105.2  31.5 2.2 NS 1.6 NS 0.4 NS
FVI (cm) 18.6  11.9 17.9  7.1 18.2  8.3 3.6 NS 2.2 NS 1.7 NS
DT (ms) 198  71.4 205  75 205  80 3.5 NS 3.5 NS 0 NS
DFT (ms) 313  98 353  71 362  88 12.7 0.02 15.6 0.004 2.5 NS
QRS (ms) 134  37 187  39 178  36 37.5 0.001 30.9 0.001 4.8 0.04
*Paired t test. Data are presented as the mean value  SD.
DFT  diastolic filling time; DT  deceleration time; EF  ejection fraction; Emax  maximum protodiastolic mitral flow; FVI  flow–velocity integral; FVI Ao  aortic
flow–velocity integral; IRT  isovolumetric relaxation time; LV  left ventricular; LVEDD  left ventricular end-diastolic diameter; LVESD  left ventricular end-systolic
diameter; MR  mitral regurgitation; NS  not significant; RV  right ventricular.
Table 3. Comparison Between Group A and Group B Patients
Group A (n  14) Group B (n  30)
Group A vs.
Group B
RV LV
Difference
(%)
p
Value* RV LV
Difference
(%)
p
Value*
p
Value†
EF (%) 53.8  12.9 55.6  11.1 3.5 NS 34.7  11.5 37.1  11.4 6.9 0.004 NS
LVEDD (mm) 50.4  6.1 50.0  6.6 0.8 NS 60.6  10.2 60.6  10.4 0 NS NS
LVESD (mm) 34.6  5.7 33.0  6.3 3.7 0.03 47.6  11.3 47.3  11.4 0.6 NS NS
IRT (ms) 67.9  25.7 70.2  24.1 3.4 NS 85.3  30.8 82.6  29.3 3.2 NS NS
MR (score) 2.2  1.0 1.5  0.7 31.8 0.005 1.6  0.7 1.5  0.7 6.3 0.02 0.01
FVI Ao (cm) 18.2  6.1 18.9  6.8 3.8 NS 17.3  7.2 18.6  6.9 7.5 NS NS
Emax (cm/s) 107  39 109  38 1.8 NS 103.5  27.4 103.6  28.5 0 NS NS
FVI Mi (cm) 18.8  7.8 19.4  10.4 3.2 NS 17.5  6.8 17.6  7.3 0.6 NS NS
DT (ms) 210  51 207  58 1.4 NS 202.6  84.0 204.4  88.9 0.8 NS NS
DFT (ms) 347  48 372  74 0.5 NS 356.1  79.0 358.2  94.4 0.6 NS NS
QRS (ms) 179  33 168  27 6.1 NS 191  39 186  34 3.0 NS NS
*Paired t test. †Unpaired t test for group A versus B. Data are presented as the mean value  SD.
FVI Mi  mitral flow–velocity integral; other abbreviations as in Table 2.
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tricular stimulation, and cardiac adaptation to chronic stim-
ulation).
An increase in EF over baseline was already present as a
result of RV pacing. Because a direct improvement of
cardiac function by RV pacing is unlikely, this improvement
seems likely to be due to the effects of rhythm regularization
and the reduction in the ventricular rate following AV
junction ablation, resulting in improvements in ventricular
filling, the Frank-Starling mechanism, and the interval-
force relation (7–10). In addition, RV pacing showed a
neutral effect on MR and indeed a worsening of aortic and
mitral flow, probably reflecting the asynchronous contrac-
tion caused by nonphysiologic pacing from the apex of the
RV (1,2). Thus, the cardiac performance after AV junction
ablation and RV pacing is the net result of two opposite
effects.
Left ventricular pacing, compared with RV pacing, sub-
stantially reduced the magnitude of MR and did not worsen
aortic and mitral flow. The lessened MR tended to lower
the EF because of higher afterloading conditions on the LV
present during MR, unless inotropic/contractile perfor-
mance was improved. In one study (11), functional MR was
reduced in patients in sinus rhythm, and this effect was
directly related to the increased closing force. In the present
study, the EF improved by a further 6%, as compared with
RV pacing (17% vs. baseline). Thus, the improvement of
EF in the presence of less MR implies even more benefit
from LV pacing. On the other hand, the aortic flow did not
improve with LV pacing, as much as expected from the
reduction of MR. Small changes in aortic flow may indicate
that only a small reduction in MR took place. In brief, the
observed modifications were generally modest and, in some
way, contrasting. Anyway, in general, it seems that LV
pacing is able to counteract some of the adverse effects of
RV pacing.
The acute hemodynamic effects of LV pacing were
similar in the patients with preserved and depressed systolic
function, as well as in patients with and without native
LBBB. This finding is original. Indeed, until now, LV and
biventricular pacing modes have been studied mainly in
patients with severely compromised LV systolic function
and LBBB. Pacing from the apex of the RV causes an
electrocardiographic pattern of LBBB. In one study (12)
performed in patients with otherwise normal hearts, the
presence of LBBB was associated with a significant deteri-
oration of cardiac function of about 10% to 20%. In the
published data, the widely used criterion for LV (or biven-
tricular) pacing is the presence of LBBB with a wide QRS
complex (13–15). The criterion of a paced QRS width
200 ms was also used in one study (14). Our observation
potentially extends the indication for LV pacing to all
patients who are candidates for ablation and pacing therapy.
This latter assertion needs to be verified in a larger popu-
lation, as the present study is probably underpowered to
show differences between subgroups.
We cannot exclude some interobserver variability of
echocardiographic evaluations that could confound the re-
sults. However, the intrapatient comparison allowed us to
reduce the interobserver variability.
There is increasing evidence for a favorable effect of
cardiac resynchronization pacing in patients with heart
failure and an intraventricular conduction delay, who are in
sinus rhythm either during acute hemodynamic (16–22) or
clinical follow-up studies (6,23–28).
Much less is known about patients with permanent AF.
An acute hemodynamic study (13) showed similar hemo-
dynamic benefits of LV-based pacing either in sinus rhythm
or in AF. Capillary wedge pressure decreased from 24 4
mm Hg at baseline to 19  5 mm Hg and 21  6 mm Hg
during LV and biventricular pacing, respectively; aortic
systolic blood pressure increased from 116  19 mm Hg
baseline to 123  18 mm Hg and 121  18 mm Hg during
LV and biventricular pacing, respectively. In another small,
acute, controlled study (6), LV pacing, compared with RV
pacing, caused an improvement of EF from 34 14% to 37
 12% and in the aortic flow integral from 19  14 cm to
21  14 cm.
The magnitude of the acute improvement is modest,
Table 4. Comparison Between Patients With LBBB and Those Without
No LBBB (n  22) LBBB (n  22)
LBBB vs.
No LBBB
RV LV
Difference
(%)
p
Value* RV LV
Difference
(%)
p
Value*
p
Value†
EF (%) 48.2  15.5 50.5  13.7 4.7 NS 33.3  9.7 35.5  10.4 6.6 0.01 NS
LVEDD (mm) 53.0  7.1 52.5  7.1 0.5 NS 61.8  11.1 62.0  11.4 0.3 NS NS
LVESD (mm) 37.7  8.4 37.1  9.5 1.6 NS 49.1  11.6 48.4  11.9 1.4 NS NS
IRT (ms) 72.5  28.6 75.7  25.7 4.4 NS 87.3  30.5 81.9  30.6 6.2 NS NS
MR (score) 1.9  0.9 1.4  0.6 26.4 0.001 1.7  0.8 1.5  0.8 11.8 NS 0.03
FVI Ao (cm) 17.2  7.3 18.4  6.2 6.9 NS 17.9  6.4 18.9  7.5 5.5 NS NS
Emax (cm/s) 108.3  36.8 109.9  35.4 1.4 NS 100.8  24.6 100.4  27.0 0.1 NS NS
FVI Mi (cm) 19.2  8.5 19.8  10.0 3.1 NS 16.5  4.8 16.3  5.6 1.3 NS NS
DT (ms) 214  61 209  68 2.3 NS 196  87 202  92 3.0 NS NS
DFT (ms) 341  64 361  81 5.8 NS 367  78 363  99 0.3 NS NS
QRS (ms) 178  38 169  27 5.1 NS 196  36 190  35 3.1 NS NS
*Paired t test. †Unpaired t test for LBBB versus no LBBB. Data are presented as the mean value  SD.
LBBB  left bundle branch block; other abbreviations as in Tables 2 and 3.
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however. It is uncertain how much these hemodynamic
effects correlate with the clinical outcome. The results of the
first randomized clinical study have recently been reported
(14). The intention-to-treat analysis did not show any
statistically significant difference in either the primary or
secondary end points between biventricular and RV pacing;
however, in the on-treatment analysis, the mean walked
distance increased significantly by 9.3% and peak oxygen
uptake increased by 13% during biventricular pacing. The
average magnitude of the effect was modest, although very
helpful, in terms of clinical improvement. This is not
surprising if we consider that, in AF patients, an improve-
ment is achieved by AV junction ablation, per se, which
reduces the amount of the potential additional benefits
obtainable through LV pacing. On the other hand, it is
apparent from the published data that upgrading to biven-
tricular pacing is greatly effective in patients with congestive
heart failure with a low EF, who have had the previous
intervention of AV junction ablation and RV pacing (29).
The results of the chronic phase the OPSITE study (4) will
hopefully help to increase our knowledge of the benefits of
different pacing sites in these patients.
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APPENDIX
For the Study Organization, Steering Committee, Execu-
tive Committee, and Data and Statistical Analysis, please
see the January 21, 2004, issue of JACC at www.cardio-
source.com/jacc.html.
238 Puggioni et al. JACC Vol. 43, No. 2, 2004
LV Versus RV Pacing January 21, 2004:234–8
